These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29849483)
1. Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review. Lang Y; Chu F; Shen D; Zhang W; Zheng C; Zhu J; Cui L Mediators Inflamm; 2018; 2018():1549549. PubMed ID: 29849483 [TBL] [Abstract][Full Text] [Related]
2. The pathogenic role of the inflammasome in neurodegenerative diseases. Freeman LC; Ting JP J Neurochem; 2016 Jan; 136 Suppl 1():29-38. PubMed ID: 26119245 [TBL] [Abstract][Full Text] [Related]
3. The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications. Yang K; Wang X; Pan H; Wang X; Hu Y; Yao Y; Zhao X; Sun T Front Immunol; 2024; 15():1441385. PubMed ID: 39076969 [TBL] [Abstract][Full Text] [Related]
4. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Cui J; Chen Y; Wang HY; Wang RF Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis-associated speck-like protein containing a caspase recruitment domain inflammasomes mediate IL-1β response and host resistance to Trypanosoma cruzi infection. Silva GK; Costa RS; Silveira TN; Caetano BC; Horta CV; Gutierrez FR; Guedes PM; Andrade WA; De Niz M; Gazzinelli RT; Zamboni DS; Silva JS J Immunol; 2013 Sep; 191(6):3373-83. PubMed ID: 23966627 [TBL] [Abstract][Full Text] [Related]
7. Inflammasomes and its importance in viral infections. Shrivastava G; León-Juárez M; García-Cordero J; Meza-Sánchez DE; Cedillo-Barrón L Immunol Res; 2016 Dec; 64(5-6):1101-1117. PubMed ID: 27699580 [TBL] [Abstract][Full Text] [Related]
8. Inflammasomes and human autoimmunity: A comprehensive review. Yang CA; Chiang BL J Autoimmun; 2015 Jul; 61():1-8. PubMed ID: 26005048 [TBL] [Abstract][Full Text] [Related]
9. The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients. Noroozi S; Meimand HAE; Arababadi MK; Nakhaee N; Asadikaram G Mol Neurobiol; 2017 May; 54(4):3031-3037. PubMed ID: 27032392 [TBL] [Abstract][Full Text] [Related]
10. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. Mason DR; Beck PL; Muruve DA J Innate Immun; 2012; 4(1):16-30. PubMed ID: 22067846 [TBL] [Abstract][Full Text] [Related]
11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases. Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768 [TBL] [Abstract][Full Text] [Related]
13. Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease. Zhang P; Shao XY; Qi GJ; Chen Q; Bu LL; Chen LJ; Shi J; Ming J; Tian B Mov Disord; 2016 Mar; 31(3):366-76. PubMed ID: 26853432 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting the inflammasome: one domain at a time. Dorfleutner A; Chu L; Stehlik C Immunol Rev; 2015 May; 265(1):205-16. PubMed ID: 25879295 [TBL] [Abstract][Full Text] [Related]
15. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections). Ringheim GE; Conant K J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426 [TBL] [Abstract][Full Text] [Related]
16. Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome. Shao QH; Zhang XL; Yang PF; Yuan YH; Chen NH Int Immunopharmacol; 2017 Aug; 49():155-160. PubMed ID: 28595078 [TBL] [Abstract][Full Text] [Related]
17. Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. Pennisi M; Crupi R; Di Paola R; Ontario ML; Bella R; Calabrese EJ; Crea R; Cuzzocrea S; Calabrese V J Neurosci Res; 2017 Jul; 95(7):1360-1372. PubMed ID: 27862176 [TBL] [Abstract][Full Text] [Related]
18. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases. Sommer A; Winner B; Prots I Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate attenuates the AIM2-induced secretion of IL-1β in human epidermal keratinocytes. Yun M; Seo G; Lee JY; Chae GT; Lee SB Biochem Biophys Res Commun; 2015 Nov; 467(4):723-9. PubMed ID: 26494301 [TBL] [Abstract][Full Text] [Related]
20. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes. Qi Y; Zhao M; Bai Y; Huang L; Yu W; Bian Z; Zhao M; Li X Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5466-75. PubMed ID: 25097240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]